Spain: Difference between revisions

From Beacon
Line 68: Line 68:


=== [[hasReport::Report:_Spanish_Group_of_Cancer_Patients_(Spain)|Report: Spanish Group of Cancer Patients]] ===
=== [[hasReport::Report:_Spanish_Group_of_Cancer_Patients_(Spain)|Report: Spanish Group of Cancer Patients]] ===
'''Sponsor, manager or home institution:''' Grupo Español de Pacientes con Cáncer.
'''Primary purpose:''' To address the specific needs and challenges faced by cancer survivors and advocate for effective measures and plans to support their well-being, reintegration into daily life, and overall quality of life after cancer treatments.
'''Type of information:''' Type of cancer and the treatment received; Time elapsed since the end of the treatments; Social, emotional and physical impacts on cancer patients.
'''Data level:''' National level.
'''Access to information:''' Access Information [https://www.gepac.es/docs/informe_supervivientes.pdf].


=== [[hasReport::Report:_EU_Country_Cancer_Profile_2023_(Spain)|Report: EU Country Cancer Profile 2023]] ===
=== [[hasReport::Report:_EU_Country_Cancer_Profile_2023_(Spain)|Report: EU Country Cancer Profile 2023]] ===

Revision as of 15:48, 24 May 2024

Go back to Cancer Centers list.

Cancer Centers

Healthcare System

Administrative or Claims Data

Registries

Databases for Clinical Trials, Surveys and Biobanks

Clinical Practices Guidelines

SEOM Guidelines

Latest Policymaking Initiatives

Reports: Ministry of Health

Report: Spanish Association Against Cancer

Report: Spanish Group of Cancer Patients

Report: EU Country Cancer Profile 2023

Sponsor, manager or home institution: OECD and European Commission.

Primary purpose: To provide reliable data on cancer prevention and care, identifying trends, disparities, and inequalities among EU Member States and regions to guide interventions under Europe's Beating Cancer Plan.

Type of information: National cancer burden; Cancer incidence and mortality; Risk factors for cancer; Early detection programs (screenings); Cancer care performance, The impact of COVID-19 on cancer care.

Data level: National level.

Access to information: Access Information [1].

Cancer-related Patient Associations and Resources

Patient Associations

Sponsor, manager or home institution: Various institutions.

Primary purpose: These associations primarily focus on cancer prevention, support, and research to improve the well-being of affected individuals and their families.

Access to information: Information [2].

Compilation: ESMO Patient Guides

Sponsor, manager or home institution: European Society for Medical Oncology.

Primary purpose: To translate complex medical language into understandable information for patients.

Available guides: Cancer Care During the COVID-19 Pandemic; Cancer-Related Pain; Immunotherapy-Related Side Effects and Their Management; Survivorship; Personalized Medicine; Colorectal Cancer; Head and Neck Cancer; Cervical Cancer; Endometrial Cancer; Glioma; Hepatocellular Carcinoma; LMA; CML; Follicular Lymphoma; Breast Cancer; Multiple Myeloma; Ovarian Cancer; Pancreatic Cancer; Non-Small Cell Lung Cancer; Testicular Cancer; Soft Tissue Sarcomas; Bone Sarcomas.

Type of information: Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, diagnosis, treatment, treatment options, care after treatment, among others.

Access to information: List of guides [3].

Quality of Life and Palliative Care Research

List of Articles: Quality of Life [4] and Palliative Care [5].